BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21258013)

  • 1. Implementation of a stroke alert protocol in the emergency department: a pilot study.
    Hoegerl C; Goldstein FJ; Sartorius J
    J Am Osteopath Assoc; 2011 Jan; 111(1):21-7. PubMed ID: 21258013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Policy: Use of intravenous tPA for the management of acute ischemic stroke in the emergency department.
    ;
    Ann Emerg Med; 2013 Feb; 61(2):225-43. PubMed ID: 23331647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis.
    Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI
    Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why are eligible thrombolysis candidates left untreated?
    Hills NK; Johnston SC
    Am J Prev Med; 2006 Dec; 31(6 Suppl 2):S210-6. PubMed ID: 17178305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA.
    Ghandehari K; Zahed AP; Taheri M; Abbasi M; Gorjestani S; Ahmadi AM; Nahayati MA
    Int J Stroke; 2009 Aug; 4(4):236. PubMed ID: 19689746
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
    Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V
    J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved time intervals by implementation of computerized physician order entry-based stroke team approach.
    Nam HS; Han SW; Ahn SH; Lee JY; Choi HY; Park IC; Heo JH
    Cerebrovasc Dis; 2007; 23(4):289-93. PubMed ID: 17199086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual TeleStroke support for the emergency department evaluation of acute stroke.
    Schwamm LH; Rosenthal ES; Hirshberg A; Schaefer PW; Little EA; Kvedar JC; Petkovska I; Koroshetz WJ; Levine SR
    Acad Emerg Med; 2004 Nov; 11(11):1193-7. PubMed ID: 15528584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twelve-month experience of acute stroke thrombolysis in Christchurch, New Zealand: emergency department screening and acute stroke service treatment.
    Fink J
    N Z Med J; 2005 May; 118(1214):U1430. PubMed ID: 15886726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the therapeutic window for tissue plasminogen activator be extended to 6 hours after stroke onset?
    Alexandrov AV
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):342-3. PubMed ID: 16265558
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of the reasons for exclusion from tPA therapy after early arrival in acute stroke patients.
    García-Moncó JC; Pinedo A; Escalza I; Ferreira E; Foncea N; Gómez-Beldarrain M; Ruiz-Ojeda J; Mateo I; Mediavilla J; Basterretxea JM
    Clin Neurol Neurosurg; 2007 Jan; 109(1):50-3. PubMed ID: 16887258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months.
    Meretoja A; Weir L; Ugalde M; Yassi N; Yan B; Hand P; Truesdale M; Davis SM; Campbell BC
    Neurology; 2013 Sep; 81(12):1071-6. PubMed ID: 23946303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective.
    Chan YF; Kwiatkowski TG; Rella JG; Rennie WP; Kwon RK; Silverman RA
    J Emerg Med; 2005 Nov; 29(4):405-8. PubMed ID: 16243196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke.
    California Acute Stroke Pilot Registry (CASPR) Investigators
    Neurology; 2005 Feb; 64(4):654-9. PubMed ID: 15728287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A web-based telestroke system facilitates rapid treatment of acute ischemic stroke patients in rural emergency departments.
    Switzer JA; Hall C; Gross H; Waller J; Nichols FT; Wang S; Adams RJ; Hess DC
    J Emerg Med; 2009 Jan; 36(1):12-8. PubMed ID: 18242925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advance hospital notification by EMS in acute stroke is associated with shorter door-to-computed tomography time and increased likelihood of administration of tissue-plasminogen activator.
    Abdullah AR; Smith EE; Biddinger PD; Kalenderian D; Schwamm LH
    Prehosp Emerg Care; 2008; 12(4):426-31. PubMed ID: 18924004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstacles to the use of intravenous tissue plasminogen activator for acute ischemic stroke. Is time the only barrier?
    Laloux P; Thijs V; Peeters A; Desfontaines P
    Acta Neurol Belg; 2007 Dec; 107(4):103-7. PubMed ID: 18416282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.